The IgG "lupus-band" deposition pattern of pemphigus erythematosus: Association with the desmoglein 1 ectodomain as revealed by 3 cases

Archives of Dermatology

Volumn 148, Issue 10, 2012, Pages 1173-1178

  Oktarina, Dyah A M ^a   Poot, Angelique M ^a   Kramer, Duco ^a   Diercks, Gilles F H ^a   Jonkman, Marcel F ^a   Pas, Hendri H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; COLLAGEN TYPE 7; COMPLEMENT COMPONENT C3; CYCLOSPORIN; DESMOGLEIN 1; DESMOGLEIN 1 ANTIBODY; ERYTHROMYCIN STEARATE; ETRETIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; METHOTREXATE; METHOXSALEN; PSORALEN;

AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPLEMENT DEPOSITION; CONTROLLED STUDY; DIAGNOSTIC ERROR; DISEASE EXACERBATION; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMATOUS PEMPHIGUS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN DEPOSITION; LIVER TOXICITY; MALE; PEMPHIGUS FOLIACEUS; PHOTOTHERAPY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PSORIASIS; PSORIASIS VULGARIS; PUSTULAR PSORIASIS; PUVA; RADIATION DOSE; SKIN BIOPSY; SKIN DEFECT; STAPHYLOCOCCUS INFECTION; TREATMENT FAILURE; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION;

AGED; AGED, 80 AND OVER; ANTIGENS, SURFACE; BASEMENT MEMBRANE; COMPLEMENT C3C; DESMOGLEIN 1; DIAGNOSTIC ERRORS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; PEMPHIGUS; PUVA THERAPY;

EID: 84867638381     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2012.1896     Document Type: Article

References (22)

1. Senear FE, Usher B. An unusual type of pemphigus combining features of lupus erythematosus. Arch Derm Syphilol. 1926;13(6):761-781.
2. Steffen C, Thomas D. The men behind the eponym: Francis E. Senear, Barney Usher, and the Senear-Usher syndrome. Am J Dermatopathol. 2003;25(5):432-436. (Pubitemid 37169473)
3. Perry HO, Brunsting LA. Pemphigus foliaceus: further observations. Arch Dermatol. 1965;91:10-23.
4. Chorzelski T, Jablońska S, Blaszczyk M. Immunopathological investigations in the Senear-Usher syndrome (coexistence of pemphigus and lupus erythematosus). Br J Dermatol. 1968;80(4):211-217.
5. Amerian ML, Ahmed AR. Pemphigus erythematosus: Senear-Usher syndrome. Int J Dermatol. 1985;24(1):16-25. (Pubitemid 15132959)
6. Jablońska S, Chorzelski T, Blaszczyk M, Maciejewski W. Pathogenesis of pemphigus erythematosus. Arch Dermatol Res. 1977;258(2):135-140. (Pubitemid 8080931)
7. Giannetti A. Immunofluorescence studies in the Senear-Usher syndrome. Arch Dermatol Forsch. 1974;248(4):287-296.
8. Bean SF, Lynch FW. Senear-Usher syndrome (pemphigus erythematosus): immunofluorescent studies in a patient. Arch Dermatol. 1970;101(6):642-645.
9. Tan EM. Special antibodies for the study of systemic lupus erythematosus: an analysis. Arthritis Rheum. 1982;25(7):753-756. (Pubitemid 12022142)
10. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.
11. Malik M, Ahmed AR. Concurrence of systemic lupus erythematosus and pemphigus: coincidence or correlation? Dermatology. 2007;214(3):231-239. (Pubitemid 46457609)
12. Amagai M. Pemphigus. In: Bolognia JL, Jorizzo JL, Rapini PR, eds. Dermatology. 2nd ed. St Louis, MO: Mosby Elsevier; 2007.
13. Kárpáti S, Stolz W, Meurer M, Krieg T, Braun-Falco O. Ultrastructural immunogold studies in two cases of linear IgA dermatosis: are there two distinct types of this disease? Br J Dermatol. 1992;127(2):112-118.
14. Morara S, van der Want JJ, de Weerd H, Provini L, Rosina A. Ultrastructural analysis of climbing fiber-Purkinje cell synaptogenesis in the rat cerebellum. Neuroscience. 2001;108(4):655-671. (Pubitemid 33660722)
15. Oktarina DA, van der Wier G, Diercks GF, Jonkman MF, Pas HH. IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis. Br J Dermatol. 2011;165(3):552-562.
16. Jacobs SE. Pemphigus erythematosus and ultraviolet light: a case report. Arch Dermatol. 1965;91:139-141.
17. Cram DL, Winkelmann RK. Ultraviolet-induced acantholysis in pemphigus. Arch Dermatol. 1965;92(1):7-13.
18. Igawa K, Matsunaga T, Nishioka K. Involvement of UV-irradiation in pemphigus foliaceus. 2004;18(2):216-217.
19. Dusek RL, Getsios S, Chen F, et al. The differentiation-dependent desmosomal cadherin desmoglein 1 is a novel caspase-3 target that regulates apoptosis in keratinocytes. J Biol Chem. 2006;281(6):3614-3624. (Pubitemid 43845979)
20. Hacker-Foegen MK, Janson M, Amagai M, Fairley JA, Lin MS. Pathogenicity and epitopecharacteristics of anti-desmoglein-1 from pemphigus foliaceus patients expressing only IgG1 autoantibodies. J Invest Dermatol. 2003;121(6):1373-1378. (Pubitemid 38005488)
21. Meurer M. Immunopathology of cutaneous lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T, eds. Cutaneous Lupus Erythematosus. Berlin, Germany: Springer; 2005:305-310.
22. Lehmann P, Homey B. Clinic and pathophysiology of photosensitivity in lupus erythematosus. Autoimmun Rev. 2009;8(6):456-461.